Frontiers in Immunology | Cancer Immunity and Immunotherapy

Review

Published on 12 Nov 2024

Biomaterials’ enhancement of immunotherapy for breast cancer by targeting functional cells in the tumor micro-environment

in Cancer Immunity and Immunotherapy

J. Paul Santerre
Yangyang Yang
Ziwei Du

Frontiers in Immunology

doi 10.3389/fimmu.2024.1492323

1,447 views

Review

Published on 12 Nov 2024

From microbes to medicine: harnessing the power of the microbiome in esophageal cancer

in Cancer Immunity and Immunotherapy

Xiaoyan Liu
Bang Li
Liping Liang
Jimin Han
Shijie Mai
Le Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1450927

2,521 views
1 citation

Original Research

Published on 12 Nov 2024

The established of a machine learning model for predicting the efficacy of adjuvant interferon alpha1b in patients with advanced melanoma

in Cancer Immunity and Immunotherapy

Linhan Jiang
Ke Su
Jing Wang
Yitong Lin
Xianya Zhao
Hengxiang Zhang
Yu Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1495329

901 views

Original Research

Published on 12 Nov 2024

Integrated multiomics characterization reveals cuproptosis-related hub genes for predicting the prognosis and clinical efficacy of ovarian cancer

in Cancer Immunity and Immunotherapy

Yang Xiaorong
Xu Lu
Xu Fangyue
Xu Chao
Gao Jun
Wen Qiang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1452294

1,468 views

Review

Published on 11 Nov 2024

The role of macrophage migratory behavior in development, homeostasis and tumor invasion

in Cancer Immunity and Immunotherapy

Michael W. Murrey
Isaac Trinstern Ng
Fiona J. Pixley

Frontiers in Immunology

doi 10.3389/fimmu.2024.1480084

1,537 views
1 citation

Systematic Review

Published on 11 Nov 2024

Current hotspots and trends in cancer metabolic reprogramming: a scientometric analysis

in Cancer Immunity and Immunotherapy

Shanshan Yang
Miaomiao Lin
Shaodong Hao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1497461

2,185 views

Original Research

Published on 11 Nov 2024

Gene expression-based modeling of overall survival in Black or African American patients with lung adenocarcinoma

in Cancer Immunity and Immunotherapy

Bin Zhu
Stephanie S. McHale
Michelle Van Scoyk
Gregory Riddick
Pei-Ying Wu
Chu-Fang Chou
Ching-Yi Chen
Robert A. Winn

Frontiers in Immunology

doi 10.3389/fimmu.2024.1478491

752 views

Systematic Review

Published on 11 Nov 2024

Comparison of adjuvant treatment regimens for high-risk hepatocellular carcinoma: a Bayesian network meta analysis and systematic review

in Cancer Immunity and Immunotherapy

Jiahao Li
Yingnan Liu
Yuqi Qiu
Chao Qu
Jiarui Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1487353

1,548 views

Review

Published on 11 Nov 2024

Comparison of differences in immune cells and immune microenvironment among different kinds of oncolytic virus treatments

in Cancer Immunity and Immunotherapy

Xiaoke Wu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1494887

1,020 views

Original Research

Published on 08 Nov 2024

Immune-based subgroups uncover diverse tumor immunogenicity and implications for prognosis and precision therapy in acute myeloid leukemia

in Cancer Immunity and Immunotherapy

Tingting Chen
Yue Zhang
Danyang Zhang
Hebing Zhou

Frontiers in Immunology

doi 10.3389/fimmu.2024.1451486

1,861 views

Review

Published on 08 Nov 2024

The role of neutrophils in osteosarcoma: insights from laboratory to clinic

in Cancer Immunity and Immunotherapy

Ming Xia
Yu Han
Lihui Sun
Dongbo Li
Chunquan Zhu
Dongsong Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1490712

1,458 views

Review

Published on 08 Nov 2024

Optimizing cancer treatment: the synergistic potential of CAR-T cell therapy and CRISPR/Cas9

in Cancer Immunity and Immunotherapy

Maryam Amiri
Amir Kian Moaveni
Masoumeh Majidi Zolbin
Behrouz Shademan
Alireza Nourazarian

Frontiers in Immunology

doi 10.3389/fimmu.2024.1462697

2,375 views
1 citation

Review

Published on 08 Nov 2024

Models of fibrolamellar carcinomas, tools for evaluation of a new era of treatments

in Cancer Immunity and Immunotherapy

Jinjia Song
Mengqi Lu
Zhiying He
Wencheng Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1459942

1,735 views

Original Research

Published on 08 Nov 2024

GPER1 signaling restricts macrophage proliferation and accumulation in human hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Yanyan Yang
Yongchun Wang
Hao Zou
Zhixiong Li
Weibai Chen
Zhijie Huang
Yulan Weng
Xingjuan Yu
Jing Xu
Limin Zheng

Frontiers in Immunology

doi 10.3389/fimmu.2024.1481972

1,045 views

Perspective

Published on 07 Nov 2024

Identifying optimal tumor-associated antigen combinations with single-cell genomics to enable multi-targeting therapies

in Cancer Immunity and Immunotherapy

Matthew A. Nix
Caleb A. Lareau
Jeffrey Verboon
David G. Kugler

Frontiers in Immunology

doi 10.3389/fimmu.2024.1492782

2,044 views
1 citation

Original Research

Published on 07 Nov 2024

Invention and characterization of a systemically administered, attenuated and killed bacteria-based multiple immune receptor agonist for anti-tumor immunotherapy

in Cancer Immunity and Immunotherapy

Michael J. Newman

Frontiers in Immunology

doi 10.3389/fimmu.2024.1462221

2,260 views

Navigation group

Articles

Biomaterials’ enhancement of immunotherapy for breast cancer by targeting functional cells in the tumor micro-environment

From microbes to medicine: harnessing the power of the microbiome in esophageal cancer

The established of a machine learning model for predicting the efficacy of adjuvant interferon alpha1b in patients with advanced melanoma

Integrated multiomics characterization reveals cuproptosis-related hub genes for predicting the prognosis and clinical efficacy of ovarian cancer

The role of macrophage migratory behavior in development, homeostasis and tumor invasion

Current hotspots and trends in cancer metabolic reprogramming: a scientometric analysis

Gene expression-based modeling of overall survival in Black or African American patients with lung adenocarcinoma

Comparison of adjuvant treatment regimens for high-risk hepatocellular carcinoma: a Bayesian network meta analysis and systematic review

Comparison of differences in immune cells and immune microenvironment among different kinds of oncolytic virus treatments

Immune-based subgroups uncover diverse tumor immunogenicity and implications for prognosis and precision therapy in acute myeloid leukemia

The role of neutrophils in osteosarcoma: insights from laboratory to clinic

Optimizing cancer treatment: the synergistic potential of CAR-T cell therapy and CRISPR/Cas9

Models of fibrolamellar carcinomas, tools for evaluation of a new era of treatments

GPER1 signaling restricts macrophage proliferation and accumulation in human hepatocellular carcinoma

Identifying optimal tumor-associated antigen combinations with single-cell genomics to enable multi-targeting therapies

Invention and characterization of a systemically administered, attenuated and killed bacteria-based multiple immune receptor agonist for anti-tumor immunotherapy